Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹1,459Cr
Rev Gr TTM
Revenue Growth TTM
23.17%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

APEX
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 1.3 | -17.0 | -17.9 | -35.8 | -23.7 | -26.7 | -17.1 | 55.8 | 22.1 | 38.8 | 19.5 | 14.6 |
| 204 | 241 | 222 | 140 | 160 | 175 | 196 | 227 | 191 | 243 | 227 | 251 |
Operating Profit Operating ProfitCr |
| 3.6 | 5.1 | 7.7 | 5.7 | 0.8 | 5.8 | 2.0 | 1.7 | 3.3 | 6.0 | 4.8 | 5.1 |
Other Income Other IncomeCr | -5 | 0 | 1 | 1 | 1 | 0 | 1 | 2 | 1 | 3 | 9 | 4 |
Interest Expense Interest ExpenseCr | 2 | 3 | 3 | 2 | 2 | 2 | 3 | 3 | 1 | 2 | 1 | 1 |
Depreciation DepreciationCr | 4 | 5 | 5 | 3 | 1 | 4 | 4 | 4 | 4 | 4 | 4 | 3 |
| -3 | 5 | 11 | 4 | 0 | 5 | -2 | 0 | 3 | 13 | 16 | 13 |
| 1 | 1 | 3 | 1 | 0 | 1 | 0 | 0 | 1 | 4 | 4 | 3 |
|
Growth YoY PAT Growth YoY% | -155.0 | -80.3 | -38.6 | -61.7 | 91.0 | 4.1 | -120.0 | -107.4 | 644.4 | 139.5 | 810.8 | 4,686.4 |
| -1.9 | 1.4 | 3.5 | 2.0 | -0.2 | 2.0 | -0.8 | -0.1 | 1.0 | 3.5 | 5.0 | 3.8 |
| -1.3 | 1.2 | 2.7 | 0.9 | -0.1 | 1.2 | -0.5 | -0.1 | 0.6 | 2.9 | 3.8 | 3.2 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 15.8 | 42.9 | -12.4 | -5.4 | -1.0 | 13.2 | 15.6 | -24.9 | 1.2 | 17.8 |
| 563 | 654 | 889 | 785 | 740 | 728 | 840 | 987 | 763 | 788 | 911 |
Operating Profit Operating ProfitCr |
| 6.7 | 6.3 | 11.0 | 10.3 | 10.5 | 11.1 | 9.3 | 7.8 | 5.1 | 3.1 | 4.9 |
Other Income Other IncomeCr | 5 | 11 | 20 | 21 | 19 | 8 | 6 | 2 | 3 | 5 | 17 |
Interest Expense Interest ExpenseCr | 10 | 11 | 9 | 7 | 11 | 16 | 17 | 15 | 10 | 9 | 5 |
Depreciation DepreciationCr | 5 | 6 | 9 | 11 | 15 | 22 | 19 | 19 | 15 | 15 | 14 |
| 30 | 37 | 113 | 94 | 81 | 61 | 56 | 51 | 20 | 6 | 45 |
| 11 | 12 | 33 | 33 | 20 | 16 | 15 | 15 | 5 | 2 | 12 |
|
| | 32.6 | 214.8 | -23.1 | -0.3 | -27.0 | -7.3 | -12.7 | -59.3 | -73.5 | 751.8 |
| 3.1 | 3.6 | 7.9 | 7.0 | 7.3 | 5.4 | 4.4 | 3.4 | 1.8 | 0.5 | 3.5 |
| 7.9 | 10.5 | 28.0 | 19.4 | 19.4 | 14.2 | 13.1 | 11.5 | 4.7 | 1.2 | 10.6 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 24 | 24 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 |
| 49 | 85 | 271 | 324 | 365 | 409 | 437 | 459 | 466 | 463 | 478 |
Current Liabilities Current LiabilitiesCr | 92 | 140 | 119 | 145 | 206 | 189 | 174 | 114 | 121 | 105 | 111 |
Non Current Liabilities Non Current LiabilitiesCr | 13 | 27 | 10 | 9 | 24 | 28 | 35 | 10 | 16 | 14 | 10 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 116 | 191 | 290 | 264 | 335 | 386 | 412 | 334 | 363 | 354 | 375 |
Non Current Assets Non Current AssetsCr | 63 | 86 | 141 | 246 | 291 | 271 | 266 | 280 | 271 | 259 | 255 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 37 | 14 | 33 | 49 | 58 | 13 | 36 | 121 | 11 | 50 |
Investing Cash Flow Investing Cash FlowCr | -16 | -29 | -58 | -114 | -44 | -14 | -10 | -22 | -8 | -2 |
Financing Cash Flow Financing Cash FlowCr | -20 | 17 | 85 | 7 | -14 | 4 | -27 | -99 | -2 | -49 |
|
Free Cash Flow Free Cash FlowCr | 21 | 14 | 33 | 50 | 59 | 0 | 25 | 100 | -1 | 46 |
| 192.9 | 57.3 | 41.7 | 80.6 | 96.1 | 29.2 | 86.5 | 337.8 | 76.5 | 1,294.3 |
CFO To EBITDA CFO To EBITDA% | 90.1 | 32.4 | 30.0 | 54.7 | 67.0 | 14.2 | 41.2 | 145.9 | 27.1 | 199.3 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 1,909 | 1,029 | 527 | 648 | 869 | 603 | 616 | 658 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 24.1 | 16.9 | 8.7 | 14.6 | 21.2 | 16.8 | 42.2 | 169.8 |
Price To Sales Price To Sales | 0.0 | 0.0 | 1.9 | 1.2 | 0.6 | 0.8 | 0.9 | 0.6 | 0.8 | 0.8 |
Price To Book Price To Book | 0.0 | 0.0 | 6.3 | 2.9 | 1.3 | 1.5 | 1.9 | 1.2 | 1.2 | 1.3 |
| 1.8 | 2.3 | 17.5 | 12.6 | 7.8 | 8.8 | 11.9 | 8.2 | 17.3 | 28.8 |
Profitability Ratios Profitability Ratios |
| 22.6 | 23.9 | 29.6 | 33.6 | 30.7 | 32.4 | 33.6 | 30.7 | 30.0 | 28.6 |
| 6.7 | 6.3 | 11.0 | 10.3 | 10.5 | 11.1 | 9.3 | 7.8 | 5.1 | 3.1 |
| 3.1 | 3.6 | 7.9 | 7.0 | 7.3 | 5.4 | 4.4 | 3.4 | 1.8 | 0.5 |
| 27.0 | 22.6 | 31.7 | 21.9 | 16.5 | 12.6 | 11.6 | 11.3 | 4.9 | 2.5 |
| 25.8 | 23.0 | 26.2 | 17.1 | 15.3 | 10.1 | 8.8 | 7.3 | 2.9 | 0.8 |
| 10.6 | 9.1 | 18.4 | 11.9 | 9.7 | 6.7 | 6.1 | 5.8 | 2.3 | 0.6 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Company Overview**
Apex Frozen Foods Ltd is one of India’s leading integrated exporters of processed shrimp, specializing in high-quality, frozen seafood products. Established in 1995 as **Apex Exports**, a partnership firm, the company evolved into a private limited entity and went public with an **IPO on BSE and NSE in September 2017**. Over the years, Apex has transformed from a standalone processor into a fully vertically integrated player across the shrimp value chain—from hatchery to export.
Headquartered in **Andhra Pradesh**, a region accounting for 60–65% of India's shrimp farming output, the company leverages strategic geographical positioning to ensure logistical efficiency and farm-to-market speed. It operates under both **customer-owned brands** and its own premium labels: **Bay Fresh, Bay Harvest, and Bay Premium**.
---
### **Business Model & Vertical Integration**
Apex Frozen Foods follows a **fully integrated business model**, encompassing:
- **Hatchery operations** (breeding SPF shrimp seed)
- **Pre-processing and processing**
- **Cold storage and export logistics**
- **Dedicated reefer truck fleet** for finished goods
This integration ensures control over quality, supply chain traceability, and compliance with stringent international standards in developed markets.
---
### **Operational Infrastructure (As of Nov 2025)**
#### **1. Hatcheries (3 in total)**
- **Annual breeding capacity**: 1.2 – 1.4 billion **Specific Pathogen Free (SPF)** shrimp seeds
- Locations: Bhogapuram (Visakhapatnam), Srikakulam, and Ongole (Andhra Pradesh)
- Supplies quality seed to over 3,000 farmers across Andhra Pradesh, Odisha, and West Bengal
- **Farm buyback program** initiated to secure raw material supply and ensure quality traceability
#### **2. Processing Facilities (2 owned plants)**
| Unit | Location | Ready-to-Cook (RTC) | Ready-to-Eat (RTE) | Cold Storage |
|------|--------|---------------------|---------------------|---------------|
| Unit 1 | Kakinada | 9,240 MTPA | – | 1,000 MT |
| Unit 2 | G. Ragampeta | 15,000 MTPA | 10,000 MTPA | 2,500 MT |
| **Total** | | **24,240 MTPA** | **10,000 MTPA** | **3,500 MT** |
- **Total processing capacity**: **34,240 MTPA**
- G. Ragampeta plant (20,000 MT) commissioned in **March 2020**, with 50% dedicated to value-added RTE production
- Pre-processing unit at **Tallarevu** boosts peeled & de-veined (P&D) input for value-added lines
#### **Strategic Location & Logistics**
- **20 km** from **Kakinada Port**
- **150 km** from **Vishakhapatnam (Vizag) Port**
- Within **20–200 km** of major shrimp farms, enabling rapid sourcing and freshness
---
### **Product Portfolio**
Apex offers a comprehensive range of frozen shrimp products, categorized into:
| Category | Key Products |
|--------|-------------|
| **Base** | Head-On, Whole Headless, Easy Peel |
| **Peeled** | P&D, Tail-Off, Tail-On |
| **Specialty** | Butterfly, Skewered, Seasoned |
| **Ready-to-Eat (RTE)** | Cooked & P&D, Breaded, Par-Fried, Shrimp Rings |
**RTE products** are a strategic growth driver, targeting **convenience-focused retail consumers** in the U.S. and EU. These high-margin offerings now account for **15–26% of total sales** (up from 15% in FY21), with expectation of further growth.
---
### **Markets & Diversification Strategy**
#### **Primary Export Markets (Q1 FY26)**
| Market | Sales Share | Notes |
|-------|------------|-------|
| **USA** | ~55% | Largest market; health-conscious consumer base |
| **European Union** | ~30% | Second-largest; steady volume growth |
| **Non-U.S. Markets (incl. UK, China, ASEAN)** | ~45% | Reflecting diversification success |
| **UK** | ~6% of total sales | Key component of "Other" markets |
- **Exports constitute ~94% of total turnover**
- Customers: **B2B partners** including foodservice companies, retail chains, club stores, and distributors
#### **Recent Market Shifts**
- **U.S. demand softened** in 2024–25 due to macroeconomic headwinds, inventory overhang, and **threat of 25% U.S. countervailing duties** (preliminary 4.36% imposed in FY24)
- Customer order delays and sourcing shifts to **Ecuador and Indonesia**
- Company accelerating **diversification into EU, UK, and Scandinavia**
---
### **Key Strategic Developments (2020–2025)**
| Year | Milestone |
|------|---------|
| **2016–2019** | Established 3 owned hatcheries for backward integration |
| **2017** | Listed on BSE/NSE via IPO; launched pre-processing unit in Kakinada |
| **2020** | Commissioned 20,000 MT plant at G. Ragampeta; launched 5,000 MT RTE capacity |
| **May 2023** | Commissioned **additional 5,000 MT RTE line**, doubling RTE capacity to **10,000 MTPA** |
| **June 2025** | **EU approval secured** for G. Ragampeta facility — enabling **first-time RTE exports to EU** |
| **Sep 2025** | **Approval received** to build **second RTE-dedicated facility** in G. Ragampeta for EU market expansion |
---
### **Regulatory & Competitive Advantage**
- Recognized as a **Star Export House** by **Directorate General of Foreign Trade (DGFT)**
- All facilities **EU-listed**, with **BRC, FDA, HACCP, and FSSAI certifications**
- **EU approval (June 2025)** ends a **five-year wait**, unlocking high-value RTE exports to Europe
- Competitors like **Ecuador** dominate commodity exports but lag in **value-added infrastructure** and **skilled labor**
- **India’s cost advantage + processing capabilities** position Apex favorably in global VAP (value-added products) market
---
### **Growth Strategy & Outlook**
#### **Core Focus Areas:**
1. **Value-Added Product Mix Expansion**
- Driving higher **EBITDA margins** through increased RTE sales (target: >30% of portfolio)
- RTE realization is **~20–30% higher** than base products
2. **Geographic Diversification**
- Expand in **EU, UK, Scandinavia, Canada, and new ASEAN markets**
- **FTA with EU & UK** expected to eliminate **4.3% import duty**, boosting competitiveness
- U.S. trade tensions underscore need for reduced regional dependency
3. **Capacity Utilization & Efficiency**
- Current utilization **<50% of processing capacity**, offering significant **volume headroom**
- Minimal further CapEx needed; new RTE capacity added via **low-cost expansion (~$1M)**
4. **North America Market Development**
- Establishing **wholly-owned U.S. subsidiary** to enhance logistics and customer support (expected from FY26)
---
### **Challenges & Risk Mitigation**
| Risk | Mitigation Strategy |
|------|---------------------|
| **U.S. tariffs & trade barriers** | Accelerate EU and Canada expansion; diversify customer base |
| **Red Sea shipping disruptions** | Secure long-term reefer contracts; reroute through alternative hubs |
| **Reliance on imported SPF broodstock** | Invest in internal breeding R&D |
| **Farm-level supply volatility** | Expand farm buyback program; support farmers with inputs and seed |
| **Pending FTAs (India–UK/EU)** | Leverage existing EU approval to build order pipeline in anticipation of duty-free access |
---
### **Financial & Operational Highlights (FY24 & Q1 FY26)**
- **Net Revenue (Q4 FY24)**: ₹162 crores (down from ₹212 cr YoY due to U.S. slowdown)
- **EU Sales Growth (FY24)**: **+31% YoY**; share rose from 19% to **30%** of total sales
- **RTE Share in Sales (FY24)**: **26%** (up from 15% in FY21)
- **Gross Debt (Mar 2024)**: Reduced to **₹1,069 crores** from ₹1,668 crores (Mar 2022)
- **Debt-to-Equity Ratio**: **0.22** – strong balance sheet
- **CapEx**: Capital-efficient expansions; **no major greenfield projects planned**